Страна: Канада
Език: английски
Източник: Health Canada
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)
AURO PHARMA INC
J01CA04
AMOXICILLIN
500MG
CAPSULE
AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500MG
ORAL
30/100/500
Prescription
AMINOPENICILLINS
Active ingredient group (AIG) number: 0131314006; AHFS:
APPROVED
2012-06-27
Auro-Amoxicillin Product Monograph Page 1 of 28 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr Auro-Amoxicillin Amoxicillin Capsules Capsules, 250 mg and 500 mg amoxicillin (as amoxicillin trihydrate), Oral BP Antibiotic AURO PHARMA INC. 3700 Steeles Avenue West, Suite # 402 Woodbridge, Ontario, L4L 8K8 Canada Date of Initial Authorization: JUN 27, 2012 Date of Revision: NOV 02, 2023 Submission Control Number: 276668 Auro-Amoxicillin Product Monograph Page 2 of 28 RECENT MAJOR LABEL CHANGES 3 SERIOUS WARNINGS AND PRECAUTIONS BOX 10/2023 7 WARNINGS AND PRECAUTIONS 10/2023 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................... 4 1 INDICATIONS ...................................................................................................................... 4 1.1 Pediatrics ............................................................................................................................... 4 1.2 Geriatrics ............................................................................................................................... 4 2. CONTRAINDICATIONS ........................................................................................................ 4 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ..................................................................... 5 4 DOSAGE AND ADMINISTRATION ......................................................................................... 5 4.1 Dosing Considerations ........................................................................................................... 5 4.2 Recommended Dose and Dosage Adjustment Usual Dosage ............................................... 5 4.4 Administration ....................................................................................................................... 7 4.5 Missed Dose .......................................................................................................................... 7 5 OVERDOSAGE .... Прочетете целия документ